U.S. Markets close in 3 hrs 31 mins

Ajovy: One of Teva Pharmaceutical’s Key Growth Drivers

Margaret Patrick
Ajovy: One of Teva Pharmaceutical’s Key Growth Drivers

Teva or Endo: Which Is the Better Pick in May?(Continued from Prior Part)Teva’s performanceIn the first quarter, Teva Pharmaceutical (TEVA) reported revenue of $4.29 billion, a YoY (year-over-year) fall of 15.20% and $89.76 million lower than the